Supposedly the beneficiary of the vaccine story as one of the appointees approved by the government. A duopoly with DPHARMA. However... their price & volume action is dimming fast..
The cup and handle pattern is invalidated.
The recent decision to prioritize Pfizer vaccine over Sinovac really trigger a sell-down on PHARMA stock price with high volume. Expect continued selling in the coming days.
https://www.straitstimes.com/asia/se-asia/malaysias-kelantan-opts-for-pfizer-biontech-covid-19-vaccine-over-sinovac-other-states
The rest of the vaccine related stock hype: Kanger, Solution, HWGB, Yongtai, Bintai , yet to see any new development as the government controlled tightly the distribution and sale of vaccine to the public from third parties.
Disclaimer
This information only serves as reference information and does not constitute a buy or sell call. Conduct your own research and assessment before deciding to buy or sell any stock
The cup and handle pattern is invalidated.
The recent decision to prioritize Pfizer vaccine over Sinovac really trigger a sell-down on PHARMA stock price with high volume. Expect continued selling in the coming days.
https://www.straitstimes.com/asia/se-asia/malaysias-kelantan-opts-for-pfizer-biontech-covid-19-vaccine-over-sinovac-other-states
The rest of the vaccine related stock hype: Kanger, Solution, HWGB, Yongtai, Bintai , yet to see any new development as the government controlled tightly the distribution and sale of vaccine to the public from third parties.
Disclaimer
This information only serves as reference information and does not constitute a buy or sell call. Conduct your own research and assessment before deciding to buy or sell any stock
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.